Kalytera Therapeutics, Inc.
Kalytera Therapeutics, Inc. (TSXV:KALY) (OTC:KALTF) is pioneering the development of CBD therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of CBD medicines for a range of important unmet medical needs, with an initial focus on GVHD and treatment of acute and chronic pain.
Directions to listing
Send Message to listing owner
Listing Title: Kalytera Therapeutics, Inc.